(3-methoxy-4-(4-nitrophenoxy)phenyl)methanol | 916793-29-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (3-methoxy-4-(4-nitrophenoxy)phenyl)methanol
• 英文别名: 3-methoxy-4-(4-nitrophenoxy)benzyl alcohol；[3-Methoxy-4-(4-nitrophenoxy)phenyl]methanol
• CAS: 916793-29-8
• 化学式: C₁₄H₁₃NO₅
• 分子量: 275.261
• InChiKey: YXGMDKNWHSNHKI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  84.5
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (3-methoxy-4-(4-nitrophenoxy)phenyl)methanol 在 亚硝酸特丁酯 、 铁粉 、 iron(II) sulfate 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 15.0h， 生成 3-methoxy-4-phenoxybenzyl alcohol
  参考文献：
  名称：

  新型二苯醚：恶性疟原虫和大肠杆菌的烯醇ACP还原酶的设计，对接研究，合成和抑制。

  摘要：

  我们设计了一些新颖的二苯醚，并使用Autodock确定了它们与恶性疟原虫的烯丙基酰基载体蛋白还原酶（ENR）的结合能。从中，我们合成了有前途的化合物，并测试了它们对恶性疟原虫以及大肠杆菌的ENR的抑制活性。这些化合物中的一些显示出对PfENR的纳摩尔抑制作用和对EcENR的低微摩尔抑制作用。它们还对恶性疟原虫和大肠杆菌的体外培养物表现出低的微摩尔效价。这些化合物的结构-活性关系的研究为进一步改进新型二苯醚的设计铺平了道路，该新型二苯醚对纯化的酶和病原体具有增强的活性。

  DOI：

  10.1016/j.bmc.2006.07.034
• 作为产物：
  描述：

  3-甲氧基-4-(4-硝基苯氧基)苯甲醛 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 以91%的产率得到(3-methoxy-4-(4-nitrophenoxy)phenyl)methanol
  参考文献：
  名称：

  新型二苯醚：恶性疟原虫和大肠杆菌的烯醇ACP还原酶的设计，对接研究，合成和抑制。

  摘要：

  我们设计了一些新颖的二苯醚，并使用Autodock确定了它们与恶性疟原虫的烯丙基酰基载体蛋白还原酶（ENR）的结合能。从中，我们合成了有前途的化合物，并测试了它们对恶性疟原虫以及大肠杆菌的ENR的抑制活性。这些化合物中的一些显示出对PfENR的纳摩尔抑制作用和对EcENR的低微摩尔抑制作用。它们还对恶性疟原虫和大肠杆菌的体外培养物表现出低的微摩尔效价。这些化合物的结构-活性关系的研究为进一步改进新型二苯醚的设计铺平了道路，该新型二苯醚对纯化的酶和病原体具有增强的活性。

  DOI：

  10.1016/j.bmc.2006.07.034

文献信息

• Water-Controlled Regioselectivity of Pd-Catalyzed Domino Reaction Involving a C−H Activation Process: Rapid Synthesis of Diverse Carbo- and Heterocyclic Skeletons
  作者：Zhiyao Lu、Chunmei Hu、Jiajie Guo、Jing Li、Yuxin Cui、Yanxing Jia

  DOI：10.1021/ol902672a

  日期：2010.2.5

  A palladium-catalyzed domino reaction involving a C-H activation process to synthesize diverse carbo- and heterocyclic skeletons was developed. H2O (as cosolvent) is used to control the regioselectivity.
• Mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and structural templates
  申请人：Surolia Avadhesha

  公开号：US20100190832A1

  公开（公告）日：2010-07-29

  Transthyretin (TTR), a tetrameric thyroxine (T4) carrier protein, is associated with a variety of amyloid diseases. Derivative of biphenyl ethers (BPE), which are shown to interact with a high affinity to its T4 binding site thereby preventing its aggregation and fibrillogenesis. They prevent fibrillogenesis by stabilizing the tetrameric ground state of transthyretin. Two compounds (2-(5-mercapto-[1,3,4]oxadiazol-2-yl)-phenol and 2,3,6-trichloro-N-(4H-[1,2,4]triazol-3-yl) exhibit the ability to arrest TTR amyloidosis. The dissociation constants for the binding of BPEs and compound 11 and 12 to TTR correlate with their efficacies of inhibiting amyloidosis. They also have the ability to inhibit the elongation of intermediate fibrils as well as show nearly complete (>90%) disruption of the preformed fibrils. Biphenyl ethers and compounds 11 and 12 as very potent inhibitors of TTR fibrillization and inducible cytotoxicity.
• Design of Mechanism-Based Inhibitors of Transthyretin Amyloidosis:  Studies with Biphenyl Ethers and New Structural Templates
  作者：Sarika Gupta、Manmohan Chhibber、Sharmistha Sinha、Avadhesha Surolia

  DOI：10.1021/jm0700159

  日期：2007.11.1

  Transthyretin (TTR), a tetrameric thyroxine (T4) carrier protein, is associated with a variety of amyloid diseases. In this study, we explore the potential of biphenyl ethers (BPE), which are shown to interact with a high affinity to its T4 binding site thereby preventing its aggregation and fibrillogenesis. They prevent fibrillogenesis by stabilizing the tetrameric ground state of transthyretin. Additionally, we identify two new structural templates (2-(5-mercapto-[1,3,4]oxadiazol-2-yl)-phenol and 2,3,6-trichloro-N-(4H-[1,2,4]triazol-3-yl) represented as compounds 11 and 12, respectively, throughout the manuscript) exhibiting the ability to arrest TTR amyloidosis. The dissociation constants for the binding of BPEs and compound 11 and 12 to TTR correlate with their efficacies of inhibiting amyloidosis. They also have the ability to inhibit the elongation of intermediate fibrils as well as show nearly complete (> 90%) disruption of the preformed fibrils. The present study thus establishes biphenyl ethers and compounds 11 and 12 as very potent inhibitors of TTR fibrillization and inducible cytotoxicity.
• Novel diphenyl ethers: Design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli
  作者：Manmohan Chhibber、Gyanendra Kumar、Prasanna Parasuraman、T.N.C. Ramya、Namita Surolia、Avadhesha Surolia

  DOI：10.1016/j.bmc.2006.07.034

  日期：2006.12

  We designed some novel diphenyl ethers and determined their binding energies for Enoyl-Acyl Carrier Protein Reductase (ENR) of Plasmodium falciparum using Autodock. Out of these, we synthesized the promising compounds and tested them for their inhibitory activity against ENRs of P. falciparum as well as Escherichia coli. Some of these compounds show nanomolar inhibition of PfENR and low micromolar

  我们设计了一些新颖的二苯醚，并使用Autodock确定了它们与恶性疟原虫的烯丙基酰基载体蛋白还原酶（ENR）的结合能。从中，我们合成了有前途的化合物，并测试了它们对恶性疟原虫以及大肠杆菌的ENR的抑制活性。这些化合物中的一些显示出对PfENR的纳摩尔抑制作用和对EcENR的低微摩尔抑制作用。它们还对恶性疟原虫和大肠杆菌的体外培养物表现出低的微摩尔效价。这些化合物的结构-活性关系的研究为进一步改进新型二苯醚的设计铺平了道路，该新型二苯醚对纯化的酶和病原体具有增强的活性。